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The activity of myogenic regulatory factor (MRF) genes is essential for vertebrate muscle development, whereas invertebrate muscle
development is largely independent of MRF function. This difference indicates that myogenesis is controlled by distinct regulatory mechanisms
in these two groups of animals. Here we used overexpression and gene knockdown to investigate the role in embryonic myogenesis of the
single MRF gene of the invertebrate chordate Ciona intestinalis (Ci-MRF). Injection of Ci-MRF mRNA into eggs resulted in increased
embryonic muscle-specific gene activity and revealed the myogenic activity of Ci-MRF by inducing the expression of four muscle marker
genes, Acetylcholinesterase, Actin, Troponin I, and Myosin Light Chain in non-muscle lineages. Conversely, inhibiting Ci-MRF activity with
antisense morpholinos down-regulated the expression of these genes. Consistent with the effects of morpholinos on muscle gene activity, larvae
resulting from morpholino injection were paralyzed and their “muscle” cells lacked myofibrils. We conclude that Ci-MRF is required for larval
tail muscle development and thus that an MRF-dependent myogenic regulatory network probably existed in the ancestor of tunicates and
vertebrates. This possibility raises the question of whether the earliest myogenic regulatory networks were MRF-dependent or MRF-
independent.
© 2006 Elsevier Inc. All rights reserved.Keywords: Ascidian; Chordate; Tunicate; MyoD; Myogenic regulatory network; MyogenesisIntroduction
Myogenic regulatory factor (MRF) genes are a family of
conserved basic-helix–loop–helix (b-hlh)-containing tran-
scription factors that participate in muscle development in a
wide variety of animals (reviewed by Baylies and Michelson,
2001; Pownall et al., 2002; Buckingham et al., 2003;
Tajbakhsh, 2005; Tapscott, 2005). Vertebrates possess four
MRF genes, MyoD, Myf5, myogenin, and MRF4 whose
combined activity is required for muscle development.
Despite their considerable functional redundancy, gene
knockout experiments indicate that Myf5 and MyoD function
to specify the skeletal muscle lineage (Rudnicki et al., 1993;
Kablar et al., 2003), whereas myogenin plays a key role in
terminal differentiation (Hasty et al., 1993; Nabeshima et al.,⁎ Corresponding author. Fax: +1 401 456 9620.
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doi:10.1016/j.ydbio.2006.09.0431993; Venuti et al., 1995). MRF4 appears to function in both
muscle specification and differentiation (Kassar-Duchossoy et
al., 2004). In contrast, most invertebrates have a single MRF
gene, which in those that have been studied (C. elegans and
Drosophila) plays a much less important role in myogenesis
than do the MRFs of vertebrates. These differences indicate
that vertebrate and invertebrate myogenesis have significantly
different requirements for MRF gene activity.
Ascidians are marine invertebrates of the subphylum
Tunicata that together with the subphyla Cephalochordata
and Vertebrata comprise the phylum Chordata. Recent studies
indicate that tunicates are the closest living relatives of
vertebrates (Ruppert, 2005; Delsuc et al., 2006), and thus that
ascidians are phylogenetically well suited for studying how
differences in invertebrate and vertebrate MRF activities may
have evolved. Like most invertebrates, ascidians have a single
MRF gene that is equally related by sequence to the four
vertebrate MRFs (Araki et al., 1994; Meedel et al., 1997;
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two transcripts that are present in embryonic and adult body
wall muscle but not in heart muscle, and whose expression is
closely correlated with muscle differentiation under a variety
of circumstances (Meedel et al., 1997, 2002). These
observations provide strong circumstantial evidence that it
has a significant role(s) in myogenesis. Originally, this gene
was named CiMDF (C. intestinalis Muscle Determination
Factor; Meedel et al., 1997) and has also been referred to as
Ci-MyoD (e.g. Imai et al., 2004). Here we suggest the name
Ci-MRF (C. intestinalis Myogenic Regulatory Factor) to
indicate its equal relationship with the four vertebrate MRFs
and that, as shown in this communication, it functions as a
myogenic regulatory factor.
Muscle of the ascidian larva is confined to two bilaterally
symmetric bands in the tail that flank a central notochord and a
dorsal hollow nervous system (Katz, 1983; Satoh, 1994). Its
organization and function most resemble vertebrate axial
muscle (Bone, 1989), and it is a striated member of the
troponin/tropomyosin-regulated class of muscles that includes
vertebrate skeletal and cardiac muscles and ascidian body wall
muscle (Meedel and Hastings, 1993). Species of ascidians
typically used for embryological studies have only 36–42
mononucleate tail muscle cells with thoroughly documented
lineage histories (Conklin, 1905; Ortolani, 1955; Nishida,
1987). Muscle in the anterior and middle of the tail is designated
as the primary lineage and develops autonomously under the
control of asymmetrically localized maternal determinants;
muscle in the posterior is designated as the secondary lineage
and develops conditionally in response to intercellular signaling
(Meedel et al., 1987; Nishida, 1990). Therefore, ascidian larval
muscle is a well-characterized and exceptionally simple tissue
whose development can be studied at the resolution of
individual cells.
In this study, we present a comprehensive analysis of Ci-
MRF expression and function that appeared previously in
abstract form (Meedel et al., 2006). In situ hybridization
experiments showed that Ci-MRF is expressed abundantly only
in cells that are uniquely fated to form muscle. Gene
overexpression and knockdown experiments demonstrated
that Ci-MRF is a bona fide MRF whose myogenic activity is
necessary for larval muscle development. Our results lead us to
conclude that an MRF-dependent regulatory network is a shared
feature of tunicate and vertebrate myogenesis.
Materials and methods
Embryo culture and injections
Adult C. intestinalis were obtained from the Station Biologique in Roscoff,
France. Eggs and sperm were removed surgically from adults, and eggs were
dechorionated chemically as described by Mita-Miyazawa et al. (1985).
Fertilizations were done using dilute sperm suspensions, and embryos were
raised on 1% agarose-coated petri dishes at 16–19°C in artificial sea water
(Hudson and Lemaire, 2001) containing 50 μg/ml kanamycin. Microinjections
were done as previously described (Hudson et al., 2003); each egg was injected
with ∼30 pl of test solution. We initially tested a variety of concentrations of
RNAs or morpholinos, but in the experiments reported we injected CiMRFb
mRNA at 0. 5 mg/ml and morpholinos at 0.5–1.0 μM.mRNA injection constructs and morpholinos
In order to create a full-length cDNA, genomic DNAwas amplified with the
primers 5′-TGACAGAATTCCACCATGACTTGCATCTCTCTAGAGG-3′
and 5′-CAACCAGACGCCATATTACTGAGC-3′ using PFU polymerase
(Stratagene). This resulted in ∼320 bp fragment, which included the translation
start site of CiMRFb RNA (shown in bold in the first primer); this fragment was
digested with EcoRI and SacI and inserted together with a ∼2.3 kb SacI/NotI
fragment encoding most of CiMRFb RNA (Genbank accession numberU80079;
Meedel et al., 1997) into EcoRI/NotI digested pRN3 (Lemaire et al., 1995) to
create pRN3CiMRFb. mRNA was synthesized from SfiI linearized plasmids
using mMessage Machine kits (Ambion). Antisense morpholinos were
purchased from Gene Tools, LLC. Morpholinos used to target Ci-MRF
transcripts were ATGTCATACTACCGGCTGGATTTGC (MO1640) and CTA-
GAGAGATACACGTCATCGTATA (MO4468).
In situ hybridization and acetylcholinesterase histochemistry
In situ hybridization was done using digoxigenin-labeled antisense RNA
probes essentially as described by Wada et al. (1995). Incubation times for color
development ranged from 20 min to 48 h depending on probes. Probes to detect
mRNAs for Ci-Muscle Actin (Hudson and Yasuo, 2005), Ci-MRF (CiMRFa,
Meedel et al., 1997) and Ci-Troponin I (pcTp2; MacLean et al., 1997) have been
described previously; Ci-Myosin Alkali Light Chain (cilv022o11) was obtained
from the Ciona gene collection plates (e.g. Satou et al., 2002). Hoechst staining
was done as described by Hudson and Yasuo (2005).
For acetylcholinesterase (AChE) histochemistry, embryos were fixed for
40 min on ice in seawater containing 4% para-formaldehyde. AChE activity was
localized according to the method of Karnovsky and Roots (1964). Incubation
times for color development were 2–4 h at room temperature.
Transmission electron microscopy
Larvae were fixed for electron microscopy using the method of Crowther
and Whittaker (1986). Briefly, larvae were collected when uninjected controls
were actively swimming ∼20 h post fertilization and fixed for 30 min at room
temperature in 2.5% glutaraldehyde, 0.2 M phosphate buffer pH 7.2, 0.34 M
NaCl. After rinsing in 0.2 M phosphate buffer pH 7.2, specimens were post-
fixed for 30 min at room temperature in 1% OsO4, 1.5% potassium ferrocyanide
and 2.5% bicarbonate buffer pH 7.2, rinsed with water and en-bloc stained in 2%
uranyl acetate overnight at 4°C on a rotary shaker. Following dehydration
through an ethanol series, larvae were embedded in Spurr resin and baked for
18 h at 60°C. Thin sections (silver) were made with diamond knife using a
Reichert OM U3 ultramicrotome and observed directly or after post staining
with uranyl acetate and lead citrate, with a Hitachi H600 electron microscope at
100 kV. Photographs were digitally scanned without significant image
modification.
Results
Zygotic expression of Ci-MRF coincides with restriction to
muscle fate
We previously showed that Ci-MRF is expressed only in
muscle cells of tail formation stage embryos (Meedel et al.,
1997). However, the observation that MRF transcripts exist at
low concentrations in non-muscle lineage cells of many
organisms at early developmental stages (e.g. Harvey, 1990;
Scales et al., 1991; George-Weinstein et al., 1996; Gerhart et al.,
2000; Kiefer and Hauschka, 2001), coupled with the occurrence
of minute levels of the small Ci-MRFmRNA (CiMRFa) in eggs
and early-cleavage stage Ciona embryos (Meedel et al., 2002),
prompted us to reexamine the spatial pattern of Ci-MRF
expression by in situ hybridization. Ci-MRF transcripts were
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blastomere pair (Fig. 1A). The nuclear localization of these
transcripts indicates that Ci-MRF expression has just begun and
is consistent with previous RT-PCR studies showing that
zygotic transcription of Ci-MRF begins between 3 and 4 h (32-
to 64-cell stages) post fertilization (Meedel et al., 2002).
Notably, the B7.4 blastomeres of the 44-cell embryo are the
only muscle lineage cells whose fate is restricted to form muscle
at this stage (Nishida, 1987). We did not detect Ci-MRF
transcripts in eggs or earlier cleavage stage embryos, which
have been shown to contain an extremely low level of maternal
CiMRFa mRNA (Meedel et al., 2002). At the 64-cell stage, the
B7.8 blastomere pair becomes fate restricted to form muscle
(Nishida, 1987), and it was at this time that these cells first
expressed Ci-MRF. With subsequent divisions of the B7.4 cells
leading to the 76-cell stage and the B7.8 cells leading to the 110-
cell stage, three and then four cell pairs respectively expressed
Ci-MRF (76-cell stage: B7.8, B8.7, B8.8; 110-cell stage: B8.7,
B8.8, B8.15, B8.16). Up to and including the 110-cell stage, weFig. 1. Localization of Ci-MRF transcripts during embryogenesis shown by in situ
and neural plate stage embryos. The developmental stage is indicated in each panel
that have neural and muscle fates. Only cells on one side of the bilaterally symmetr
indicate muscle (A9.31) and neural (A9.32) precursors; in order to distinguish th
embryos in h after fertilization, when reared at 18°C are 44-cell (3.75 h), 64-cell (4
Diagram of the primary muscle lineage; cells that are fate restricted to form muscl
(C) Vegetal and lateral views of Ci-MRF transcript distribution in a single neurula
dorsal (lower row) views of Ci-MRF transcript distribution during tail formation
Approximate developmental ages at 18°C are 9 h (Early), 11 h (Middle) and 13 h (
ep (epidermis) and N (notochord). All scale bars are 50 μm.never detected Ci-MRF expression in the B7.5 cells (see
diagram in Fig. 2), which are the other progenitors of the
primary muscle lineage. The B7.5 blastomere pair is not fate
restricted and will give rise to cardiac muscle and the anterior-
most larval tail muscle (Nishida, 1987). Therefore, the zygotic
expression of Ci-MRF in the primary muscle lineages occurs
exclusively in cells whose fate is restricted to tail muscle
(Fig. 1B). These results are in agreement with those of Imai
et al. (2004) except that they did not report on Ci-MRF
expression as early as the 44-cell stage.
Unlike the primary lineage, secondary muscle lineage cells
sometimes expressed Ci-MRF before they were fate restricted
to muscle. Expression was detected in the A8.16 cells at the
110-cell/early gastrula stages in approximately one-third of
embryos analyzed (arrows in Fig. 1A); this cell pair has both
neural and muscle fates before dividing to form the fate
restricted A9.31 (muscle) and A9.32 (neural) cells (Nishida,
1990; Nicol andMeinertzhagen, 1988; Cole andMeinertzhagen,
2004). Following cleavage, only the A9.31 cell continues tohybridization. (A) Vegetal views of transcript distribution in cleavage, gastrula
; arrows in the 110-cell embryo and early gastrula embryo indicate A8.16 cells
ical embryo are labeled in each panel. Labels on the neural plate stage embryo
ese cells, this embryo was stained with Hoechst dye. Approximate ages of
.25 h), 76-cell (4.5 h), 110-cell (5 h), gastrula (6 h) and neural plate (7 h). (B)
e are shown in red. Numbers at the top of the diagram indicate the cell stage.
stage embryo (∼8 h post fertilization at 18°C). (D) Lateral (upper row) and
; orientation of each embryo is anterior (top, left), posterior (bottom, right).
Late). Abbreviations are A (anterior), P (posterior), An (animal), Vg (vegetal),
Fig. 2. In situ hybridization of early gastrula-stage embryos injected with CiMRFb mRNA. Embryos shown represent the two most common classes of result we
obtained; the percentage of embryos in each class is indicated as are the number of embryos analyzed (N). Embryos in lateral view are oriented with the vegetal half
facing left, and animal half facing right. Scale bar is 50 μm. The diagram shows an early gastrula stage embryo in vegetal view.
336 T.H. Meedel et al. / Developmental Biology 302 (2007) 333–344express Ci-MRF, and transcript levels become comparable to
the primary lineage (Fig. 1A).
At none of the later stages examined was there any indication
that Ci-MRF was expressed in cells other than those that give
rise solely to muscle. Muscle cells in neurula stage embryos are
bounded by epidermis and confined to the posterior–vegetal
region of the embryo (Conklin, 1905); only these cells
expressed Ci-MRF at this stage (Fig. 1C). Later, during tail
formation, the muscle cells form two lateral bands in the tail,
which flank the central notochord and are bounded by
epidermis. Viewed laterally, these cells appear as a mass that
fills the tail. Viewed from the dorsal or ventral surfaces, this
mass of muscle cells appears “U-shaped” in early–middle tail
formation stages; later it separates at the posterior end to form
two bilateral bands of muscle (Conklin, 1905). Only cells
corresponding to these locations expressed Ci-MRF during tail
formation stages (Fig. 1D).
Ci-MRF overexpression increases muscle gene activity and
leads to the formation of ectopic muscle-like cells
A hallmark of MRF family genes is their ability to direct
myogenesis when they are experimentally activated in non-
muscle cells (e.g. Davis et al., 1987; Weintraub et al., 1989;
Choi et al., 1990; Venuti et al., 1991; Fukushige and Krause,
2005). We studied whether Ci-MRF had this potential by
injecting CiMRFb mRNA into eggs, which were then fertilized
and examined for muscle-specific gene activity at early gastrula
or early–mid tail formation stages. We focused on CiMRFb
because the protein it encodes contains all known MRF
functional domains, whereas CiMRFa lacks Domain III
(Rhodes and Konieczny, 1989) and thus might not be a fullyfunctional MRF. Four muscle-specific genes were assayed in
order to assess diverse aspects of the differentiated phenotype:
Acetylcholinesterase served as a marker of the cholinergic
system and was assayed histochemically; muscle Actin and
Troponin I (TnI) served as thin filament markers and Myosin
(alkali) light chain (MLC) served as a thick filament marker. All
three mRNAs encoding proteins of the contractile apparatus
were assayed by whole mount in situ hybridization.
Embryos reared from CiMRFb mRNA-injected eggs cleaved
normally and developed into normal looking early gastrula
stage embryos (Fig. 2), making it possible to identify cell
lineages. As reflected in the in situ hybridization staining
intensity, the muscle lineage cells of injected embryos showed
dramatic increases in the levels of all three contractile apparatus
mRNAs assayed (Fig. 2). In addition to enhanced activity
within the primary muscle lineage itself, injected embryos also
expressed these three genes in B-lineage cells that give rise to
endoderm, mesenchyme and notochord (Conklin, 1905;
Nishida, 1987). For Actin and MLC, we observed two major
phenotypes that together accounted for ≥90% of injected
embryos (Fig. 2). Most commonly these two genes were
expressed in all B-lineage cells, while less often they were
primarily active in the mesenchyme lineages in addition to the
primary muscle. Some A-lineage cells also expressed Actin and
MLC transcripts at lower levels. TnI appeared to be particularly
sensitive to CiMRFb injection, and its transcripts were detected
at high levels in all the vegetal cells (i.e. both A- and B-lineages)
in about 70% of injected embryos (Fig. 2). In about one-quarter
of the embryos, TnI expression, while still apparent in multiple
A-lineage cells, was most abundantly expressed in the B-
lineage (Fig. 2). We never observed expression of any of the
contractile protein genes analyzed in the animal half of the
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(Fig. 2).
Embryos reared to the tail formation stage from eggs injected
with CiMRFb mRNA did not develop normally; instead they
formed amorphous embryos without a distinct head or tail, but
with an obvious epidermal covering (Fig. 3A). Acetylcholines-
terase, Actin andMLC expression patterns were similar in these
specimens: epidermal cells were uniformly negative, and
approximately three-quarters of the interior cells were strongly
positive while the remaining cells were negative or weakly
positive. Consistent with what we observed in early gastrula
stage embryos, TnI expression was particularly sensitive to
CiMRFb mRNA since all interior cells of injected embryos
were strongly positive. As with the other three markers, TnI
transcripts were not detected in the surrounding epidermal cells
(see Fig. 3 and legend).
The widespread muscle-specific gene activity present in
these embryos, together with the observation that muscle-
specific gene expression occurred in non-muscle lineages of
CiMRFb-injected embryos at the early gastrula stage, suggests
that myogenesis was taking place in non-muscle cells of these
embryos. This was confirmed by taking advantage of the ability
of embryos to differentiate when cytokinesis is prevented with
cytochalasin B (Whittaker, 1973). Embryos were treated with
cytochalasin B beginning at the 64-cell stage and then assayedFig. 3. Muscle gene expression in tail formation stage embryos injected with CiMRF
no clear axial organization. Numbers of injected embryos examined (N) are indica
specimens are shown for each marker examined. The apparent hybridization signal in
not observed when these embryos were examined microscopically; therefore, this “si
and by photographing them in glycerol, which renders them somewhat transparent. S
64-cell stage until early tail formation. Injected embryos had an average of 18 acetylc
could not be determined. Number of injected embryos examined (N) is indicated atfor acetylcholinesterase activity or the presence of TnI
transcripts at the early–mid tail formation stage. Under these
conditions, uninjected, cleavage-arrested specimens expressed
Acetylcholinesterase and TnI in an average of six primary
muscle lineage blastomeres (Fig. 3B); in contrast, acetylcholi-
nesterase activity was seen in an average of 18 cells in CiMRFb
injected specimens. Most of these additional cells were B-
lineage blastomeres (cells in the lower half of the embryo
shown), although some corresponded to the A-lineage (cells in
the upper half of the embryo shown). Consistent with previous
experiments indicating that its expression is especially respon-
sive to Ci-MRF overexpression, TnI was expressed throughout
the vegetal half of cleavage-arrested embryos.
MO-treatment inhibits muscle-specific gene activity
We used antisense morpholino oligonucleotides (MO) to
investigate the effect on muscle development of down-
regulating Ci-MRF activity. Two MOs were designed for
these experiments: the first (MO1640) targeted nucleotides 16–
40, which corresponds to most of the 5′ untranslated region of
Ci-MRF mRNAs exclusive of the 5′ trans-spliced leader
sequence (Vandenberghe et al., 2001); the second (MO4468)
targeted nucleotides 44–68 which includes the translation start
site at nucleotides 50–52. MOs targeting these sequences areb mRNA. (A) Control embryos are shown in lateral views; injected embryos had
ted at the bottom of the figure. Two representatives from the pool of injected
the epidermis of CiMRFb mRNA-injected embryos assayed for TnI mRNAwas
gnal” is an artifact caused by the intense staining reaction seen in these embryos
cale bar is 100 μm. (B) Embryos cleavage-arrested with cytochalasin B from the
holinesterase positive cells; the number of TnI positive cells in injected embryos
the bottom.
Fig. 4. MOs targeting Ci-MRF mRNA reduce muscle gene expression in early
gastrula embryos. Representative staining reactions are shown for control
embryos assayed for MLC and TnI expression. The majority of MO-treated
embryos assayed for MLC expression were negative as shown in the panels.
Remaining embryos were significantly down-regulated; 21% for MO1640 and
35% for MO4468, or resembled the controls (not shown). Essentially, all
embryos assayed for TnI expression were negative when treated with either MO.
The average number of positive cells after each treatment is indicated below the
panels and includes all cells expressing a given marker irrespective of the
strength of the signal detected. The number of embryos examined (N) is shown
in parentheses. Scale bar=50 μm.
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blocking translation. The two MOs gave similar results,
indicating that they were likely to be specifically targeting Ci-
MRF mRNAs.
Embryos reared from eggs injected with either MO cleaved
and developed into early gastrula stage embryos with normal
morphology that were then analyzed for MLC and TnIFig. 5. MOs targeting Ci-MRF mRNA reduce muscle gene expression in tail forma
carried out at the mid tail formation stage; MLC and TnI in situ hybridizations were d
right corner of each MO-injected embryo refer to the stain intensity relative to the st
classifying embryos (e.g. 3+, 2+, 1+, 0+) is described in the text. Examples are sho
percentage of embryos in that class is shown in parentheses. The total number of M
figure. Scale bars=100 μm.expression (Fig. 4). Both MOs reduced muscle gene expression
significantly, although we did observe some variability in the
response of individual embryos to MO injection. MO injection
dramatically suppressed TnI expression; with either MO, no
TnI transcripts were detected in >90% of embryos. This result
shows that both MOs are effective in disrupting normal
myogenesis. Furthermore, MLC expression was also signifi-
cantly affected with down-regulation or loss of expression
observed in >75% of the embryos injected with either MO1640
or MO4468.
Middle and late tail formation stage embryos raised from
MO-injected eggs were also examined for muscle gene
expression. Like embryos examined at the early gastrula
stage, we noted some variability in the response of individual
embryos. Therefore, we devised a classification system to score
the extent of muscle marker gene expression as determined by
histochemistry (AChE) or in situ hybridization (Actin, MLC,
TnI). This system was: 3+ for expression level similar to
controls, 2+ for reduced level of expression relative to control,
1+ for greatly reduced level of expression relative to control, 0+
for no detectable expression. Morphologically at least 80% of
the MO-treated embryos were scored “grossly normal”meaning
they had a clearly distinct head and tail. The most obvious
abnormality was tail malformation that ranged from relatively
minor kinks (Fig. 5) to stunted tails less than 50% of normal
length (not shown). Others readily observed that aspects of
development appeared normal in MO-treated embryos; for
example, pigment formation in the otolith was comparable to
controls (Fig. 5).
All four markers of muscle development assayed were
down-regulated in MO-injected tail formation stage embryos
(Fig. 5). MLC and Actin were most affected with expression oftion stage embryos. AChE histochemistry and Actin in situ hybridization were
one at the late tail formation stage. Numbers outside of parentheses in the lower
ain intensity of control embryos reacted for the same time. The system used for
wn of the two most abundant embryo classes for each marker tested, and the
O-injected embryos analyzed for each marker (N) is shown at the bottom of the
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regulated (1+) in >80% of MO-injected embryos. TnI transcript
levels and AChE activity were also significantly reduced by
MO injection with the majority of embryos falling into the two
most reduced categories (0+ and 1+), although both markers
appear less sensitive than either MLC or Actin to MO injection.
MO-treated larvae are paralyzed and do not form myofibrils
Our results with molecular markers indicate that myogenesis
is significantly perturbed following inhibition of Ci-MRF
function. In order to address the consequences of blocking Ci-
MRF activity on structural and functional aspects of muscle
development, we examined muscle ultrastructure in control and
MO-treated larvae that exhibited grossly normal morphology
(Figs. 6A, B). Ascidian larval tail muscle has been thoroughly
characterized at the ultrastructural level (reviewed in Meedel,
1998). These cells have extremely high concentrations of
centrally positioned mitochondria and, relative to vertebrate
skeletal muscle, a rather modest number of sarcomeric
myofibrils that are restricted to the peripheral cytoplasm near
the plasma membrane. These features were apparent in sections
through muscle cells of control larvae, in which the peripheral
myofibrils showed the expected cross-striated pattern (Figs. 6C,Fig. 6. Morphological comparison of normal (control) and morpholino-treated la
morpholino-injected (B) larvae. Transmission electron micrographs of the larval tail s
Sections are slightly oblique to the longitudinal axis. The box in panel C encloses an
cross-striated myofibrils; this area is seen at higher magnification in panel E where wh
of cytoplasm near the cell membrane of a “muscle” cell of an MO-injected embryo. Th
Scale bars are 100 μm (A), 1 μm (C, D).E). Sections through the corresponding cells of MO-treated
larvae (identified unambiguously by position in the tail and high
concentration of mitochondria) occasionally showed traces of
what appeared to be disorganized myofilaments, but more
typically no muscle ultrastructural elements were observed
(Figs. 6D, F). Consistent with the loss of organized myofibrils,
MO-treated larvae rarely showed any signs of movement and
those that did (<10%) exhibit only very occasional weak
twitches and not the frenetic movements typical of normal
larvae. These results demonstrate that Ci-MRF is required to
form functional tail muscle cells.
Discussion
Ci-MRF expression
In recent years, several genes have been found that regulate
ascidian myogenesis. At the head of this regulatory hierarchy in
the primary muscle lineage is the maternally expressed gene
macho-1 (Nishida and Sawada, 2001). At least three early-
acting zygotic genes also appear to be important regulators of
myogenesis, Tbx6b, Tbx6c and ZicL (Imai et al., 2002; Yagi
et al., 2004, 2005). Our findings add Ci-MRF to this group of
genes that are crucial for myogenesis and indicate that one ofrvae. Differential interference contrasts light micrographs of normal (A) and
howing muscle cells in control (C, E) and morpholino-treated (D, F) specimens.
area near the cell membrane of a muscle cell from a control larva that is rich in
ite arrows point to myofibrils. The box in panel D encloses a corresponding area
is area is seen at higher magnification in panel F; note the absence of myofibrils.
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activate Ci-MRF expression. This view is supported by recent
studies that showed that Ci-MRF transcript levels were
enhanced in macho-1 overexpressing embryos (Yagi et al.,
2004) and down-regulated in embryos treated with either
Tbx6b/c/d or ZicL MOs (Imai et al., 2006).
Our results with Ci-MRF have striking parallels to earlier
research on Brachyury, a gene encoding a T-box transcription
factor expressed in ascidian notochord (Yasuo and Satoh, 1993,
1994, 1998). Brachyury expression is detected only in
notochord lineage cells whose fates are restricted, and its
initiation coincides precisely with the time of fate restriction
(Yasuo and Satoh, 1994). Furthermore, Brachyury is required
for the differentiation of notochord cells and is sufficient to
induce notochord marker expression in certain non-notochord
lineages (Takahashi et al., 1999; Hotta et al., 1999). Thus,
Brachyury functions in the notochord much in the same way
that our results indicate Ci-MRF functions in muscle cells.
Parallels can also be drawn with other key regulatory genes such
as Twist-like1 in the mesenchyme (Imai et al., 2003) and Lhx3
in the endoderm (Satou et al., 2001). Therefore, the early
activation of key lineage-restricted transcription factors appears
to be a common mechanism used by ascidian embryos to ensure
the robust and spatially appropriate expression of terminal
differentiation genes. Furthermore, while we did not investigate
such a possibility in this study, Ci-MRF may also repress the
activity of non-muscle genes. This would be consistent with the
suggestion that vertebrate MyoD may act as a repressor through
its association with histone deacetylases (Tapscott, 2005).
Ci-MRF is required for normal muscle development
Antisense MOs were used to examine the extent to which
muscle development depended on Ci-MRF. MO-treated
embryos expressed muscle genes at reduced levels compared
with controls and developed into larvae that were almost
always paralyzed and whose “muscle” cells lacked myofibrils.
Notably, these specimens were quite normal in appearance,
indicating that MOs were not generally detrimental to
embryogenesis and that the effects we observed were specific
to muscle development. Therefore, our results provide strong
evidence that Ci-MRF is a key regulator of muscle
development. This conclusion is supported by a recent
large-scale study of the early embryonic gene regulatory
network of C. intestinalis, which also reported that an MO
targeting Ci-MRF down-regulated Actin transcript levels
(supplementary material in Imai et al., 2006).
Muscle gene expression was not uniformly affected in MO-
treated embryos. A clear example of this was the variable
responses of TnI and MLC. Transcripts of both genes were
reduced effectively at the early gastrula stage by MO treatment,
but while MLC transcripts were still dramatically down-
regulated at the early–mid tail formation stage TnI transcripts
were less affected at this time. Because MLC expression was
strongly reduced throughout development, it is unlikely that the
MOs lost their efficacy at later stages. Instead, these results
indicate that other regulatory mechanisms may act in parallelwith Ci-MRF to control TnI expression at later stages or that
inactivation of Ci-MRF results in misregulation of other
regulatory factors that lead to TnI expression.
MO treatment usually did not eliminate muscle marker
expression. This result was not entirely surprising because
expression of some terminal muscle differentiation genes, such
as Actin and myosin heavy chain (MHC), is initiated before Ci-
MRF is expressed '(Satou et al., 1995), and, thus, some Ci-
MRF-independent muscle gene activity was expected. We also
cannot exclude the possibility that some of the muscle gene
activity we noted was Ci-MRF-dependent. However, we feel
that this is unlikely since injecting both MOs together gave
essentially the same results as injecting MOs separately (data
not shown) consistent with the view that individual MOs
efficiently targeted Ci-MRF. Development of antibodies to
assess Ci-MRF protein levels in MO-treated embryos would be
required to resolve this issue.
Ci-MRF is myogenic
CiMRFb mRNA injection resulted in muscle genes being
expressed in non-muscle lineages. This result demonstrates that
Ci-MRF is myogenic in C. intestinalis embryos and thus that it
functions as a bona fide MRF (e.g. Davis et al., 1987; Weintraub
et al., 1989; Choi et al., 1990; Venuti et al., 1991; Fukushige and
Krause, 2005). Not all cells were susceptible to myogenic
conversion by misexpressing Ci-MRF. B-line cells were most
susceptible, A-line cells were generally less susceptible, and
animal-half cells appeared to be entirely refractory. These
results are consistent with the view that MRF genes function
together with other positive and negative regulatory factors (e.g.
chromatin remodeling complexes, kinases, E-proteins, Mef2,
Id, etc.) in a complex regulatory environment (Berkes and
Tapscott, 2005; Tapscott, 2005). Thus, the distribution of such
cofactors could account for the divergent responses of different
cells to misexpression of Ci-MRF. Interestingly, mesenchyme
lineage cells were among the cells most readily converted to
muscle-like cells. Many of these cells originate from the B-line
(Nishida, 1987), and elaboration of their fate depends on
fibroblast growth factor (FGF)-dependent signals that suppress
myogenesis (Kim and Nishida, 1999, 2001; Kim et al., 2000). A
recent study showing that Ci-MRF is expressed in the B-line
mesenchyme cells of embryos treated with an MO targeting
FGF9/16/20 (Imai et al., 2006) indicates that this FGF signal
blocks Ci-MRF expression, which could otherwise lead to
myogenesis in mesenchyme lineages as happened in CiMRFb
mRNA-injected embryos.
MRF misexpression in embryos typically activates terminal
muscle genes, but the ectopic, muscle-like cells formed usually
do not become fully differentiated muscle (Hopwood and
Gurdon, 1990; Miner et al., 1992; Faerman et al., 1993;
Fukushige and Krause, 2005; but see also Ludolph et al., 1994;
Delfini and Duprez, 2004). In order to evaluate the extent of
muscle differentiation in CiMRFb mRNA-treated embryos, we
analyzed four markers that represented diverse aspects of the
muscle phenotype. All of these markers were expressed
ectopically, indicating that Ci-MRF misexpression elicits a
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use structural or physiological features such as the presence of
sarcomeres or contractility to further evaluate the extent of
ectopic myogenesis because these features do not appear until
the mid–late tail formation stage at which time the highly
abnormal morphology of CiMRFb-injected embryos prevented
us from distinguishing ectopic from normal muscle. We suspect
that elaboration of a muscle phenotype in non-muscle lineages
leads to abnormal development by interfering with cellular
activities necessary for morphogenesis.
Overexpression of Ci-MRF by mRNA injection also led to
dramatically elevated levels of terminal differentiation gene
activity within the muscle lineage. This further supports our
contention that Ci-MRF is a key regulator of myogenesis and
is consistent with the view that it may act as a rate-limiting
factor to determine the quantitative level of muscle gene
expression in embryos. The presence of GC-core E-boxes in
many potential target genes (Johnson et al., 2004, 2005;
Kusakabe et al., 2004) indicates that it could do this directly,
although its ability to regulate the expression of at least three
transcription factor genes (Imai et al., 2006) indicates that
some of these activities are indirect. Ci-MRF may also play a
role in initiating the expression of some terminal muscle
differentiation genes, consistent with properties of other
MRFs (Tapscott, 2005). Of the genes studied, TnI is a good
candidate to represent this class, as it was the most widely
misexpressed of the genes we examined in CiMRFb-injected
embryos at both the gastrula and tail formation stages. In
addition, the accumulation of TnI transcripts was most
negatively affected by MO-treatment when embryos were
examined at the early gastrula stage, which is shortly after
this gene becomes transcriptionally active (Cleto et al., 2003).
Finally, E-box elements in the 5′ upstream regulatory region
of TnI have been shown to be crucial for the expression of
electroporated reporter constructs (Johnson et al., 2004).
Evolution of MRFs
MRF genes of invertebrates and vertebrates exhibit a number
of conserved features including their sequences and expression
patterns, their capacity to elicit muscle differentiation when
expressed in cultured cells and their ability to substitute for one
another in functional tests (see recent reviews by Baylies and
Michelson, 2001; Pownall et al., 2002; Buckingham et al.,
2003; Tajbakhsh, 2005). A particularly remarkable example of
this functional conservation was the ability of the Drosophila
MRF, nautilus and chicken MyoD to rescue an MRF loss of
function mutant of C. elegans (Zhang et al., 1999). This high
level of conservation indicates that myogenic regulatory
strategies involving MRF genes are ancient and conserved.
However, vertebrates have four MRF genes whereas inverte-
brates (with the exception of cephalochordates, which have two
MRF genes; Araki et al., 1996; Schubert et al., 2003) have only
one. In addition, unlike mutations of vertebrate MRFs, which
have severe consequences for myogenesis (Hasty et al., 1993;
Nabeshima et al., 1993; Rudnicki et al., 1993; Venuti et al.,
1995; Kablar et al., 2003; Kassar-Duchossoy et al., 2004), nullmutations of invertebrate MRFs, represented by C. elegans and
D. melanogaster, have comparatively minor effects (Chen et al.,
1994; Balagopalan et al., 2001). Thus, despite a high degree of
conservation among MRF genes, that includes the functional
capabilities of the proteins themselves, vertebrate myogenesis
shows a striking reliance on MRF activity that was not seen
previously in invertebrates (reviewed by Olson and Klein, 1998;
Baylies and Michelson, 2001).
The results of the present study add a significant new
dimension to our understanding of MRF function by demon-
strating that, like vertebrates, ascidians also require MRF
activity for muscle development. Thus, an MRF-dependent
myogenic regulatory network is not strictly a vertebrate
phenomenon, and it probably existed in the ancestor of tunicates
and vertebrates. Moreover, the presence of only a single MRF
gene in ascidians indicates that such a network does not require
multiple MRF genes. These observations raise an important
question about the nature of the ancestral myogenic network:
was it MRF-dependent or MRF-independent? This question
cannot be resolved based on available information because any
scenarios that account for the distribution of MRF-dependent
and MRF-independent myogenic networks are equally likely;
i.e. gain of an MRF-dependent myogenic network in the
ascidian/vertebrate ancestor or its loss in the C. elegans/Droso-
phila ancestor is equally probable. This uncertainty underscores
the importance of studying MRF function in a wider array of
animals. For example, because gene knockdown strategies are
effective in sea urchins (e.g. Davidson et al., 2002; Duboc et al.,
2004), it should be possible to determine whether an MRF-
dependent network predates the chordates by using MO
injections to determine whether the sea urchin MRF gene
SUM-1 is required for myogenesis. Although resolving the role
of the ancestral MRF in myogensis is likely to be more difficult,
the discovery of JellyD1, a potential MRF homolog in the
hydrozoan jellyfish Podocoryne carnea (Muller et al., 2003),
indicates that this too is feasible.
Current views of the developmental basis of animal
evolution focus on changes in the design of transcriptional
regulatory systems (Davidson, 2001; Wilkins, 2002, Carroll
et al., 2005). Evolutionary changes in the role of MRF genes
without large-scale changes in the functional properties of the
proteins they encode are entirely consistent with these ideas.
Simply stated, functional comparison of MRF genes in
invertebrates, such as C. elegans and D. melanogaster, with
vertebrates and the invertebrate C. intestinalis indicates that the
roles of MRF genes in myogenesis depend more on the
regulatory environment in which they function than on
differences in the properties of the proteins they encode. The
ascidian embryo is an experimental system that is well suited for
identifying the components of this regulatory system and
determining how they function with Ci-MRF to control muscle
development.
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